Fluorocarbons and fluorinated amphiphiles in drug delivery and biomedical research

Advanced Drug Delivery Reviews

Volumn 47, Issue 2-3, 2001, Pages 209-228

  Krafft, Marie Pierre ^a  

^a INSTITUT CHARLES SADRON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COLLOIDS; FLUOROCARBONS; SURFACE ACTIVE AGENTS; TISSUE;

DRUG DELIVERY;

DRUG THERAPY;

AMPHOPHILE; CARBON DIOXIDE; FLUORINATED AMPHIPHILE; FLUORINATED LIPID; FLUORINATED SURFACTANT; FLUOROCARBON; HYDROCARBON; LIPID; PROTEIN; SURFACTANT; UNCLASSIFIED DRUG;

ACUTE RESPIRATORY FAILURE; BIOTRANSFORMATION; CLINICAL TRIAL; COLLOID; CONTROLLED DRUG RELEASE; CRYSTALLIZATION; DRUG DELIVERY SYSTEM; DRUG STRUCTURE; EMULSION; FLUORINATION; HUMAN; HYPOXIA; LIQUID VENTILATION; MEDICAL RESEARCH; MICELLE; OXYGEN TRANSPORT; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REVIEW; TISSUE OXYGENATION;

EID: 0035946616     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(01)00107-7     Document Type: Article

References (170)

1. Update on perfluorocarbon-based oxygen delivery systems
2. Fluorocarbon-based oxygen delivery: Basic principles and product development
3. Blood use and non-blood use: Designing blood substitutes
4. Fluorinated surfactants, synthesis, properties, applications
5. Van der Waals volumes and radii
6. Concentrated surfactant systems
7. Theory of self-assembly of lipid bilayers and vesicles
8. Small angle neutron scattering measurements on micellar solutions of perfluor detergents
9. Are fluorocarbon chains 'stiffer' than hydrocarbon chains? Dynamics of end-to-end cyclization in a C8F16 segment monitored by fluorescence
10. A model for the chains in amphiphilic aggregates. 2. Thermodynamic and experimental comparisons for aggregates of different shape and size
11. A room-temperature transition in polytetrafluoroethylene
12. Calorimetric properties of polytetrafluoroethylene (Teflon)
13. Fluorocarbons
14. Perfluorochemical emulsions for intravascular use: Principles, materials and methods
15. Physical chemistry of fluorocarbons
16. Highly fluorinated systems for oxygen transport, diagnosis and drug delivery
17. Highly fluorinated amphiphiles and colloidal systems, and their applications in the biomedical field - A contribution
18. Fluorocarbon emulsions - Designing an efficient shuttle service for the respiratory gases - The so-called 'blood substitutes'
19. Fluorocarbons and fluorosurfactants for in vivo oxygen transport (blood substitutes), imaging and drug delivery
20. Adsorption of fluorocarbon and hydrocarbon surfactants to air-water, hexane-water, and perfluorohexane-water interfaces. Relative affinities and fluorocarbon-hydrocarbon nonideality effects
21. Fluorocarbon-hydrocarbon interactions in micelles and other lipid assemblies, at interfaces and in solutions
22. Structural studies of polymers with hydrophilic spacer groups. II. Infrared spectroscopy of Langmuir-Blodgett multilayers of polymers with fluorocarbon side chains at ambient and elevated temperatures
23. The physiochemical properties of aqueous solutions of fluorinated surfactants
24. Comparative study of fluorinated and hydrogenated nonionic surfactants. I. Surface activity properties and critical concentrations
25. 2 rule
26. Unusual micellar properties of a new class of fluorinated nonionic surfactants
27. Micelles and aggregates of fluorinated surfactants
28. Semifluorinated hydrocarbons: Primitive surfactant molecules
29. The role of perfluorochemicals in surgery and the ITU
30. Fluorocarbon-based in vivo oxygen transport and delivery systems
31. The design and engineering of oxygen-delivering fluorocarbon emulsions
32. Reassessment of criteria for the selection of perfluorochemicals for second-generation blood substitutes: Analysis of structure/property relationships
33. Blood substitutes
34. The toxicities of native and modified hemoglobins
35. Pharmacokinetics and side effects of perfluorocarbon-based blood substitutes
36. Response of the rabbit lung as a criterion of safety for fluorocarbon breathing and blood substitutes
37. Proposed mechanism of pulmonary gas trapping (PGT) following intravenous perfluorocarbon emulsion administration
38. Some morphologic effects of 'inert' particulate loading on hemopoietic elements in mice
39. Fate of perfluorochemicals in animals after intravenous injection or hemodilution with their emulsions
40. Discussion and considerations for the excretion mechanism of perfluorochemical emulsion
41. Dose related biodistribution and elimination of 100% PFOB emulsion
42. Perfluorochemical erythrocyte substitutes: Disposition and effects on drug distribution and elimination
43. A novel model describing excretion of perfluorochemicals from living organisms - Dissolution of fluorocarbons in lipid components of blood
44. Recent developments in pharmacokinetic modeling of perfluorocarbon emulsion
45. Randomized safety studies of intravenous perflubron emulsion. I. Effects on coagulation function in healthy volunteers
46. Randomized safety studies of intravenous perflubron emulsion. II. Effects on immune function in healthy volunteers
47. A new concept for the stabilization of injectable fluorocarbon emulsions
48. Improved control over particle sizes and stability of concentrated fluorocarbon emulsions by using mixed fluorocarbon/hydrocarbon molecular dowels
49. On the perfluorocarbon emulsions of second generation
50. Novel liposome systems based on the incorporation of (perfluoroalkyl)alkenes (FmHnE) into the bilayer of phospholipid liposomes
51. H) into the phospholipid bilayer of DMPC liposomes results in greater encapsulation stability
52. Hydrolysis of DMPC or DPPC by pancreatic phospholipase A2 is slowed down when (perfluoroalkyl)alkanes are incorporated into the liposomal membrane
53. Free-radical addition of iodoperfluoroalkanes to terminal alkadienes. Relative reactivity as a function of chain length and reaction conditions
54. mH in the solid state
55. Novel fluorocarbon-based injectable oxygen-carrying formulations with long-term room-temperature storage stability
56. The use of semifluorinated alkanes in blood substitutes
57. Biodistribution of mixed fluorocarbon-hydrocarbon dowel molecules used as stabilizers of fluorocarbon emulsions: A quantitative study by fluorine nuclear magnetic resonance (NMR)
58. Novel injectable fluorinated contrast agents with enhanced radiopacity
59. The acute toxicity of perfluorooctanoic and perfluorodecanoic acids in male rats and effects on tissue fatty acids
60. Health status of plant workers exposed to fluorochemicals: A preliminary report
61. Tissue distribution, metabolism, and elimination of perfluorooctanoic acid in male and female rats
62. Effects of perfluoro fatty acids on xenobiotic-metabolizing enzymes, enzymes which detoxify reactive forms of oxygen and lipid peroxidation in mouse liver
63. Fluorinated surfactants intended for biomedical uses
64. Synthesis of homogenous polyoxyethylene perfluoroalkyl surfactants
65. Design, synthesis, and evaluation of fluorocarbons and surfactants for in vivo applications: New perfluoroalkylated polyhydroxylated surfactants
66. Synthesis of long chain n-alkyllactylamines from unprotected lactose: A new series of non-ionic surfactants
67. Non-ionic surfactants derived from lactose: The N-(2-(F-alkyl)ethyl)-lactosamines and -lactobionamides
68. Carbohydrate- and related polyol-derived fluorosurfactants - An update
69. New synthetic strategy to vesicle-forming perfluoroalkylated amphiphiles
70. Nonionic amphiphilic compounds from aspartic and glutamic acids as structural mimics of lecithins
71. Synthesis of new sugar-based surfactants having biological applications: Key role of their self-association
72. Perfluoroalkylated amphiphiles with monomorpholinophosphate or dimorpholinophosphate polar head group
73. Membranes, vesicles, and other supramolecular systems made from fluorinated amphiphiles
74. New perfluoroalkyl telomeric non-ionic surfactants: Synthesis, physicochemical and biological properties
75. Disposition in rat of a new fluorinated, biocompatible, non-ionic telomeric carrier
76. Fluorinated vesicles
77. Highly effective surfactants with low hemolytic activity
78. Liquid ventilation in adults, children, and full-term neonates
79. Partial liquid ventilation with perflubron in premature infants with severe respiratory distress syndrome
80. Comparison of gas and liquid ventilation: Clinical, physiological, and histological correlates
81. Partial liquid ventilation: A multifaceted approach to acute respiratory distress syndrome
82. Pulmonary administration of vasoactive substances by perfluorochemical ventilation
83. Solubility and transport phenomena in perfluorochemicals relevant to blood substitution and other biomedical applications
84. Reduction of myocardial ischemia during percutaneous transluminal coronary angioplasty with oxygenated Fluosol
85. Perflubron emulsion delays blood transfusions in orthopedic surgery
86. A novel class of nonionic microemulsions: Fluorocarbons in aqueous solutions of fluorinated poly(oxyethylene) surfactants
87. Anomalies of partially fluorinated surfactant micelles
88. Krafft points, critical micelle concentrations, surface tension, and solubilizing power of aqueous solutions of fluorinated surfactants
89. Solubilization of water in binary mixtures of fluorocarbons and nonionic fluorinated surfactants: Existence of domains of reverse microemulsions
90. Phase and structure behavior of fluorinated nonionic surfactant systems
91. Microemulsions of perfluorinated and semi-fluorinated compounds
92. Perfluoropolyether microemulsions: Conductivity behavior of three-component W/O systems
93. Microemulsifying fluorinated oils with mixtures of fluorinated and hydrogenated surfactants
94. Tissue oxygenation with graded dissolved oxygen delivery during cardiopulmonary bypass
95. Fluorocarbons: A potential treatment of cerebral air embolism in open-heart surgery
96. Demonstration of myocardial reperfusion injury in humans: Results of a pilot study utilizing acute coronary angioplasty with perfluorochemical in anterior myocardial infarction
97. The feasibility of organ preservation at warmer temperatures
98. Aerobic preservation of organs using a new perflubron/lecithin emulsion stabilized by molecular dowels
99. Perfluorochemical emulsions and radiation therapy
100. An overview on oxygen carriers in cancer therapy
101. Influence of the 100% w/v perfluorooctylbromide (PFOB) emulsion dose on tumour radiosensitivity
102. The potential role of perfluorochemicals (PFCs) in diagnostic imaging
103. Pulmonary administration of Gentamicin during liquid ventilation in a newborn lamb lung injury model
104. Partial liquid ventilation with perfluorocarbon in the treatment of rats with lethal pneumococcal pneumonia
105. 1 during partial liquid ventilation
106. Enhanced distribution of adenovirus-mediated gene transfer to lung parenchyma by perfluorochemical liquid
107. Perflubron enhances adenovirus-mediated gene expression in lungs of transgenic mice with chronic alveolar filling
108. Perfluoropolyether microemulsions
109. Fluorocarbon gels
110. Structure of inverse micelles and emulsion-gels with fluorinated nonionic surfactants. A small-angle neutron scattering study
111. Water in fluorocarbon gel emulsions: Structure and rheology
112. Release of a model molecule from highly concentrated fluorinated reverse emulsions. Influence of the composition variables and temperature
113. Stable highly concentrated fluorocarbon gels
114. Application of fluorocarbon emulsions as components of cosmetics and medical ointments
115. Interactions between collagen and perfluorocarbon emulsions
116. Observations of a gel phase in binary mixtures of semifluorinated n-alkanes with hydrocarbon liquids
117. Melting, crystallization, and solution behavior of chain molecules with hydrocarbon and fluorocarbon segments
118. The phase behavior and gel formation of binary mixtures of carbon dioxide and semifluorinated alkanes
119. Lecithin organogel as matrix for transdermal transport of drugs
120. Self-organization of solvophobic double-chained fluorocarbon derivatives in organic media
121. Self-organization of bilayer assemblies in a fluorocarbon medium
122. Self-assembly of bilayers from double-chain fluorocarbon amphiphiles in aprotic organic solvents: Thermodynamic origin and generalization of the bilayer assembly
123. Anionic glucophospholipids - A new family of tubule-forming amphiphiles
124. Multicompartment polymeric micelles based on hydrocarbon and fluorocarbon polymerizable surfactants
125. Formulation and enhanced stability of fluoroalkyl bilayer membranes
126. Saturated and polymerizable amphiphiles with fluorocarbon chains. Investigation in monolayers and liposomes
127. Can single-chain perfluoroalkylated amphiphiles alone form vesicles and other organized supramolecular systems
128. Fluorinated phosphocholine-based amphiphiles as components of fluorocarbon emulsions and fluorinated vesicles
129. Highly stable liposomes derived from perfluoroalkylated glycerophosphocholines
130. Polymorphic phase behavior of perfluoroalkylated phosphatidylcholines
131. Phase behavior of fluorocarbon di-O-alkyl-glycerophosphoethanolamines and long-term shelf stability of fluorinated liposomes
132. Alkyl and perfluoroalkyl glycolipid-based supramolecular assemblies
133. Vesicles and other supramolecular systems from biocompatible synthetic glycolipids with hydrocarbon and/or fluorocarbon chains
134. Vesicles made of glycophospholipids with homogeneous (two fluorocarbon or two hydrocarbon) or heterogeneous (one fluorocarbon and one hydrocarbon) hydrophobic double chains
135. Magnetic resonance characterization of betaine micelles and betaine-perfluoropropylether mixed vesicles
136. Permeability and stability in buffer and in human serum of fluorinated phospholipid-based liposomes
137. + permeability, active doxorubicin encapsulation and stability in human serum
138. Extended in vivo blood circulation time of fluorinated liposomes
139. Lipid tubules: A paradigm for molecularly engineered structures
140. Fluid and solid fibers made of lipid molecular bilayers
141. Functionalized lipid tubules as tools for helical crystallization of proteins
142. Stable flexible fibers and rigid tubules made from single-chain perfluoroalkylated amphiphiles
143. Fibril-vesicle transition and their structure. Investigation by microscopy and small angle scattering
144. Enhanced proclivity to self-aggregation of phosphorus-based amphiphiles when perfluoroalkylated
145. Self-organization of single-chain fluorinated amphiphiles with fluorinated alcohols
146. Small-angle scattering and electron microscopy investigation of nanotubules made from a perfluoroalkylated glucophospholipid
147. Efficiency of non-ionic telomeric surfactants for the solubilization of subcellular fractions proteins
148. The potential of fluorinated surfactants in membrane biochemistry
149. Stabilization of integral membrane proteins in aqueous solution using fluorinated surfactants
150. On the lack of protein-solubilization properties of two perfluoroalkylated detergents, as tested with neutrophil plasma membranes
151. Synthesis and preliminary evaluation of a new class of fluorinated amphiphiles designed for in-plane immobilisation of biological macromolecules
152. Specifically designed lipid assemblies as tools for two-dimensional crystallization of soluble biological macromolecules
153. Gene transfer with a series of lipophilic DNA-binding molecules
154. Water-in-carbon dioxide microemulsions: An environment for hydrophiles including proteins
155. Carbon dioxide extraction of biomolecules
156. Design of nonionic surfactants for supercritical carbon dioxide
157. Affinity extraction into carbon dioxide. 1. Extraction of avidin using a biotin-functional fluoroether surfactant
158. 2 microemulsion
159. Gel-like networks used to sequence DNA
160. Novel affinity separations based on perfluorocarbon emulsions: Use of a perfluorocarbon affinity emulsion for the direct extraction of glucose-6-phosphate dehydrogenase from homogenised bakers yeast